Medicare fee-for-service enrollees with primary acute myeloid leukemia: An analysis of treatment patterns, survival, and healthcare resource utilization and costs

Applied Health Economics and Health Policy

Volumn 11, Issue 3, 2013, Pages 275-286

  Meyers, Juliana ^a   Yu, Yanni ^b   Kaye, James A ^a   Davis, Keith L ^a  

^a RTI HEALTH SOLUTIONS   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; GEMTUZUMAB OZOGAMICIN;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CHARLSON COMORBIDITY INDEX; CLINICAL ASSESSMENT; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; OVERALL SURVIVAL; PATIENT SELECTION; RETROSPECTIVE MEMORY; RISK FACTOR;

AGED; AGED, 80 AND OVER; DRUG THERAPY; FEE-FOR-SERVICE PLANS; FEMALE; HEALTH CARE COSTS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MEDICARE; PHYSICIAN'S PRACTICE PATTERNS; RESOURCE ALLOCATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84878758884     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/s40258-013-0032-2     Document Type: Article

References (17)

1. American Cancer Society. Leukemia - acute myeloid (myelogenous) [online]. http://www.cancer.org/acs/groups/cid/documents/webcontent/003110-pdf.pdf. Accessed 28 Feb 2012.
2. Jernal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin. 2002;52(1):23-47.
3. Appelbaum FR, Rowe JM, Radich J, et al. Acute myeloid leukemia. ASH Educ Book. 2001;2001(1):62-86. http://asheducationbook.hematologylibrary.org/content/ 2001/1/62.long.
4. Rowley JD, Alimena G, Garson M, et al. A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotype. Blood. 1982;59(5):1013-22.
5. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood. 1998;92:2322-33.
6. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER cancer statistics review, 1975-2009 (vintage 2009 populations). Bethesda: National Cancer Institute. http://seer.cancer.gov/ csr/1975-2009-pops09/. Accessed 30 Nov 2012 (based on November 2011 SEER data submission, posted to the SEER Web site, 2012).
7. Menzin J, Lang K, Earle CC, Kerney D, et al. The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med. 2002;62(14):1597-603.
8. Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002;40(8):IV55-61.
9. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol. 1997;50(8):939-45.
10. Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006;107(11):2581-8.
11. Sundararajan V, Hershman D, Grann VR, et al. Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. J Clin Oncol. 2002;20(1):173-8.
12. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-9.
14. National Cancer Institute. Procedure codes for SEER-Medicare analyses. 2010. http://healthservices.cancer.gov/seermedicare/considerations/procedure- codes.html. Accessed 14 Feb 2013.
15. Roboz GJ. Novel approaches to the treatment of acute myeloid leukemia. ASH Educ Book. 2011;2011(1):43-50.
16. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Acute myeloid leukemia V.3 (online). 2010. http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp#site. Accessed 28 Feb 2012.
17. Piana R. Geriatric oncology, a much needed discipline for future cancer care. ASCO Post. 2011;2(17). http://www.ascopost.com/articles/november-15-2011/ geriatric-oncology,-a-much-needed-discipline-for-future-cancer-care/. Accessed 28 Feb 2012.